Trial intelligence / Profile preview

Isotretinoin plus NB-UVB for psoriasis vulgaris

IRCT138812213543N1Phase 2Completed

Sponsor
Behestan Darou
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of isotretinoin in plaque psoriasis, sponsored by Behestan Darou. Started Sep 2008; status: completed.

02

Drugs

isotretinoin
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on IRCT138812213543N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138812213543N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call